Advanced Search

 

Study ID Status Title Patient Level Data
200381 Completed Post-hoc analysis of Japanese phase II data on initial Parkinson’s disease motor dysfunctions (Study ID: 200381)
200382 Completed Cost-effectiveness of combined use of ropinirole controlled-release and L-dopa compared with L-dopa monotherapy in patients with Parkinson's disease
200385 Not yet recruiting Retrospective survey of lasting, treatment-free responders with ITP after cessation of drug therapy(RELIANT). Preliminary survey.
200395 Completed Investigation of clinical use of onabotulinumtoxinA for the treatment of upper and/or lower limb spasticity in poststroke patients with spastic hemiplegia
200398 Completed A Multi-centre, Single-blind, Parallel Group, Clinical Evaluation of the Efficacy and Safety of Clindamycin 1% / Benzoyl Peroxide 3% and Azelaic Acid 20% in the Topical Treatment of Mild to Moderate Acne Vulgaris Study Listed on ClinicalStudyDataRequest.com
200400 Active not recruiting PH+oeBE-Patterns of care in HER2+ metastatic Breast cancer in Europe: patients: A representative, retrospective study in Greece
200401 Completed A Phase 1, Single Dose, Crossover, Relative Bioavailability Study of a Dolutegravir Dispersible Tablet as Compared to a Dolutegravir Pediatric Granule Formulation and Effect of Different Types of Water on the Dispersible Tablet in Healthy Volunteers(200401)
200558 Completed An Open Label Study to Evaluate the Pharmacokinetics of Fluticasone Furoate /Umeclidinium Bromide/Vilanterol (100/62.5/25 mcg) after Single and Repeat Dose Administration from a Dry Powder Inhaler in Healthy Chinese Subjects
200559 Recruiting Special drug use investigation of XYZAL® Syrup 0.05%
200561 Completed An open-label, randomized, single dose, three-way crossover, six sequence pilot study to evaluate the relative bioavailability of one amlodipine 10mg tablet and rosuvastatin 20mg tablet to two fixed dose combination tablet formulations of amlodipine (10mg) and rosuvastatin (20mg) in healthy adult male and female subjects under fasting conditions Study Listed on ClinicalStudyDataRequest.com
200585 Recruiting Special Drug Use Investigation of ALLERMIST Nasal Spray in Pediatric Patients
200587 Completed An Open Label, Randomised, Four-Period Crossover, Single Dose Study in Healthy Volunteers to Evaluate the Pharmacokinetics of FF/UMEC/VI Combination Administered at Dose Levels 100/62.5/25 mcg and 100/125/25 mcg and in Comparison with FF/VI (100/25 mcg) and UMEC/VI (62.5/25 mcg). Study Listed on ClinicalStudyDataRequest.com
200591 Completed A Single-Center In Vitro Study to Evaluate GSK1325756 Inhibition of CD11b Cell Surface Expression in Healthy Adults and Respiratory Syncytial Virus-Infected Children <2 Years (200591)
200592 Terminated Single-blind, randomised, placebo-controlled study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of repeat doses of GSK2647544 and its potential pharmacokinetic interaction with simvastatin in healthy volunteers
200596 Not yet recruiting Immunogenicity and safety study of GSK Biologicals’ candidate malaria vaccine (SB257049) given at 6, 7.5 and 9 months of age in co-administration with measles, rubella and yellow fever vaccines followed by a booster of the malaria vaccine.
200599 Completed Extension to study MALARIA-055 PRI (NCT00866619) for evaluation of long-term efficacy, safety and immunogenicity of GSK Biologicals’ candidate malaria vaccine (SB257049) in infants and children in Africa
200600 Completed Evaluation of clinical and economic benefits of fluticasone furoate compared with mometasone furoate and budesonide in the treatment of allergic rhinitis
200606 Active not recruiting Risk of Adverse Events and Costs Associated with Chronic Systemic Corticosteroid Use in UK Patients with Severe Asthma
200611 Completed Bioequivalence Study between two medications for the oral administration of 100 mg of minocycline in oral solids in healthy volunteers.
200612 Completed A protocol to collect human serum samples from healthy adults
200613 Completed An observer-blind study to evaluate the safety and immunogenicity of GSK Biologicals’ influenza vaccine(s) GSK2789869A administered in adults 65 years of age and older
200616 Completed A randomized, double-blind, placebo-controlled, three-arm trial to evaluate the effect of using whey protein and creatine supplements on muscular strength in weight-training adult males
200619 Active not recruiting A Meta-analysis Evaluation of Baseline Factors Which Correlate with High Baseline BLyS Levels (>2ng/mL) (BLISS-52 & BLISS 76)
200622 Recruiting Study 200622: A randomized, double-blind, placebo-controlled study to investigate the efficacy and safety of mepolizumab in the treatment of adolescent and adult subjects with severe hypereosinophilic syndrome
200623 Recruiting An open label, two-part, Phase I/randomized Phase II study in subjects with relapsed/refractory multiple myeloma to determine a dose of afuresertib for administration in combination with carfilzomib (Part 1) and to investigate the safety, pharmacokinetics, and clinical activity of the combination of afuresertib with carfilzomib compared with carfilzomib alone (Part 2)

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.